Cite
APA Citation
Tolcher, A., Harb, W., Sachdev, J., Papadopoulos, K., Bordoni, R., Chai, F., Larmar, M., Savage, R., Abbadessa, G., & Saleh, M. (n.d.). 338 Results from a phase 1 study of ARQ 092, a novel pan AKT-inhibitor, in subjects with advanced solid tumors or recurrent malignant lymphoma. European journal of cancer, 51, S66–. http://access.bl.uk/ark:/81055/vdc_100030627995.0x00004f